Cancer Research UK-funded scientists at the University of Cambridge create a test to predict resistance to chemotherapy. The test uses changes to cancer DNA at diagnosis to predict which patients will ...

Test, developed by University of Cambridge, looks at structure of tumour DNA and forecasts whether it will resist treatment ...

structure-similarity screening of an in-house library of 150,000 compounds was then undertaken to search for a more advanced hit(s). A: Neurite outgrowth (% of control) of a test compound (1000 ...

Tens of thousands of cancer patients going through gruelling chemotherapy could have DNA test to predict which form of the ...

A new cancer treatment that uses light could remove the need for harsh chemotherapy or radiotherapy ... This energy couples ...

The Colts have announced a new ownership structure in the wake of the death of team owner Jim Irsay last month. Irsay’s three daughters were all serving as vice-chairs of the team before their father ...

School of Science, College of Science, Engineering and Health, RMIT University, Melbourne, VIC 3000, Australia Department of Surgery, Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC ...

FIRST/ENGOT-OV44: A phase 3 clinical trial of dostarlimab (dost) and niraparib (nira) in first-line (1L) advanced ovarian cancer (aOC). This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...

1Gynaecology and obstetrics, Wuxi Maternity and Child Health Care Hospital, Women’s Hospital of Jiangnan University, Jiangnan University, Wuxi, China.